Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. - Wikidata - awgldk - TriplyDB

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.

http://www.wikidata.org/entity/Q36440373

about

Neuroprotection in Glaucoma Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma.Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage.Evidence that light modulates protein nitration in rat retina.Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model.Effect of CNTF on retinal ganglion cell survival in experimental glaucoma Association of IL1A and IL1B loci with primary open angle glaucoma.Nitric-oxide synthase and neurodegeneration/neuroprotection.Inducible nitric oxide synthase-mediated alteration of mitochondrial OPA1 expression in ocular hypertensive rats Elevated albumin in retinas of monkeys with experimental glaucoma.Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage.Toll-like receptor 4 contributes to retinal ischemia/reperfusion injury.Definition of glaucoma: clinical and experimental concepts.OPA1 expression in the normal rat retina and optic nerve Regulation of nitric oxide production by δ-opioid receptors during glaucomatous injury.A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma Vascular Endothelial Growth Factor -460 C/T BstUI Gene Polymorphism is associated with Primary Open Angle Glaucoma Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats.TNF-alpha signaling in glaucomatous neurodegeneration An applet to estimate the IOP-induced stress and strain within the optic nerve head Tetrandrine suppresses lipopolysaccharide-induced microglial activation by inhibiting NF-κB and ERK signaling pathways in BV2 cells.Systemic adeno-associated virus-mediated gene therapy preserves retinal ganglion cells and visual function in DBA/2J glaucomatous mice Enhanced Retinal Ganglion Cell Survival in Glaucoma by Hypoxic Postconditioning After Disease Onset.Glaucomatous optic neuropathy: when glia misbehave.Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences.The association between systemic oxidative stress and ocular blood flow in patients with normal-tension glaucoma.Optic nerve and neuroprotection strategies.New paradigms in the mechanisms and management of glaucoma.Diabetes mellitus as a risk factor for glaucomatous optic neuropathy.Relationship between laser speckle flowgraphy and optical coherence tomography angiography measurements of ocular microcirculation.Protective effects of melatonin in experimental free radical-related ocular diseases.Solving the lost in translation problem: improving the effectiveness of translational research.Targets of tyrosine nitration in diabetic rat retina.Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia Safety of intravitreally administered recombinant erythropoietin (an AOS thesis)Effects of aminoguanidine on retinal apoptosis in mice with oxygen-induced retinopathy.

P2860

Q26740388-05695302-AF2B-4F05-94EB-BA89B1D25B39 Q26861763-FEAFA35B-0750-4095-825E-2F2A5CB56D16 Q27007111-B4466BA3-CB35-4197-AD92-12972E23D770 Q30671362-D1F0BC2A-0DCE-4E00-9EFD-C8E41A3FC804 Q30859959-AB8D27FD-F732-43A7-9F8B-EC31C11B9B10 Q30978745-93734CB7-3810-47AF-8FAD-A462FAAA531B Q31092381-DB8F7C89-546F-4C1B-B3BC-C40D41C1D45E Q33311386-91BCA0D9-7B30-433F-B63A-A97B5BEBB5C5 Q33390314-C07E2C97-56B0-4CD3-98B6-EAE97D3A2B69 Q33611297-4C4A3AA8-D0A7-4644-B6A4-A145DB32AAE3 Q33712796-213649B1-96EC-4894-8974-3298676A4698 Q33789800-31D1A38B-FFB8-4F5A-9E71-B05377D962C9 Q33845419-D8142B73-97A1-4857-87EE-B0820951D4EC Q34057614-78099C49-D436-45E4-B8C6-DFEE71B45A06 Q34208396-ADEDD93E-71E7-4C7A-A6B0-2B5D59515B39 Q34256241-3880EAA3-901B-4DDF-B723-AC84AD1465EB Q34312557-FC73EB7D-B3BF-4A62-82DA-D3FEE11C3060 Q34362259-904D7D37-F174-4593-B65D-D0EFCE0BE323 Q34377317-6EFD340D-915E-4F55-9C61-EEBA8F197B6F Q34691790-75D80F8E-807D-48EA-9006-767EA20BFDF2 Q34734517-1F1A5A47-A0EC-4022-ACE4-BDD552EB1699 Q35084563-EEF4A16C-9320-4805-B310-31E83F27C71C Q35147990-8C31F124-8037-4FE9-8C01-9FEACFE42318 Q35221360-3292E130-1736-43B5-A7DD-80E8DCFAEC04 Q35223417-A72B9ECE-5C44-4BFE-8878-F7A56A0E39C8 Q35496394-D81E9DD5-C9AF-4B51-9A5B-84EAD7E931FF Q35501949-883F8CF2-1531-4D2C-A65E-1FDD22189339 Q35609009-4C6BFC02-EA05-4C2B-B12A-072A05DB8582 Q35677091-05F73FD5-3875-4493-8D06-DEC92EF0DCF1 Q35826618-239BF240-0611-4FB7-8B83-4E90D9AE8492 Q35944015-218A8B93-CF1E-4EAD-AFF2-28F6D6F3C07C Q35949074-F1A7DF13-0116-4399-A53A-666BF8C93B65 Q35997726-DA600D6D-58C2-403F-BBCB-7641D9E9E9A1 Q36360275-CFAFA0BB-7A69-4B69-900C-4BFFFC1BFEBE Q36379509-C30A222E-AC1A-4099-9227-0354847F0B2D Q36487221-B0E602A5-0D72-42BE-B4E0-AAACABC77975 Q36685034-BAD3AF26-583D-481C-9F31-E240777F6A05 Q36808534-6CFCF77D-C3D9-421A-ADD8-8A697AB640E6 Q37106306-8C964390-A1AA-4E05-A58D-8049E1D12C0B Q37126831-A8BEA4A4-58E0-4432-BDFA-525CE99D2CEE

P2860

Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.

http://www.wikidata.org/entity/Q36440373

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Inhibition of nitric-oxide syn ...... rat model of chronic glaucoma.

@ast

Inhibition of nitric-oxide syn ...... rat model of chronic glaucoma.

@en

type

label

Inhibition of nitric-oxide syn ...... rat model of chronic glaucoma.

@ast

Inhibition of nitric-oxide syn ...... rat model of chronic glaucoma.

@en

prefLabel

Inhibition of nitric-oxide syn ...... rat model of chronic glaucoma.

@ast

Inhibition of nitric-oxide syn ...... rat model of chronic glaucoma.

@en

P1433

Q36440373-60C2ADE0-77EF-49AE-8445-61294D6870F0

P1476

Q36440373-56CD541E-EB8D-4402-938A-E596E36DEE9F

P2093

Q36440373-108392AD-4C0E-43C9-B5DC-6CED91751E05

Q36440373-46D303AB-6986-46AB-B426-E05D0629F15C

Q36440373-F2427496-16F7-4827-AB52-682A0D873F90

P2860

Q36440373-013C0D4D-E713-4663-B0D7-483272BA226C

Q36440373-32F69B99-E44D-4AEE-8726-F7D525F68A65

Q36440373-34C107A9-B2D6-43ED-A4C8-C9377A288E93

Q36440373-59670A19-D2BF-441A-858C-B246AEBD6124

Q36440373-647856C7-6672-4FD3-B5BB-B9D9E9C0276F

Q36440373-9F6AE33D-C7BD-4EFA-ACB0-D0BED4AC1C48

Q36440373-A037A7B2-02C2-4D66-9FB2-DDC54BF44FFB

Q36440373-A1629DBC-3A13-41E3-B4D1-ACB395BEE7A5

Q36440373-A33DE2B3-36EE-43FF-99A4-8C70B25670F8

Q36440373-ACC5A9FE-67E8-457D-BB6F-C2601B930FBF

P304

Q36440373-A329801A-2511-4861-9C6D-5734675CF86C

P31

Q36440373-658E4CD2-2740-4D04-952E-16BC048305F6

P356

Q36440373-4CF40670-D5C0-439F-801C-C5786B6EC2FE

P407

Q36440373-39F81C53-CF14-440F-9823-A9251FF64C54

P433

Q36440373-F660E0AB-6C64-457A-9CD0-535AF4029B3E

P478

Q36440373-7F752B16-D993-4EA1-99D2-A1E87B8BB469

P577

Q36440373-C57A0888-28C6-42BB-8034-CBC801C074D1

P5875

Q36440373-9FFC6647-AEB4-4AE6-AEAD-8169AB86E5E3

P698

Q36440373-E26266D5-31FB-440E-A835-A9791C698BC8

P932

Q36440373-FCB388D2-99F0-4B92-A3B9-39E187DFE13A

P356

PNAS.96.17.9944

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Inhibition of nitric-oxide syn ...... rat model of chronic glaucoma.

@en

P2093

A H Neufeld

http://www.w3.org/2001/XMLSchema#string

A Sawada

http://www.w3.org/2001/XMLSchema#string

B Becker

http://www.w3.org/2001/XMLSchema#string

P2860

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.

Advanced protein glycosylation in diabetes and aging.

Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Müller cells temporarily rescues injured retinal ganglion cells.

Glaucoma: the damage caused by pressure. XLVI Edward Jackson memorial lecture.

Nitric oxide in neuronal degeneration.

Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.

Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina.

The patterns of retinal ganglion cell death in hypertensive eyes.

Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis.

Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study.

P304

9944-9948

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.96.17.9944

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

1999-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12849648

http://www.w3.org/2001/XMLSchema#string

P698

10449799

http://www.w3.org/2001/XMLSchema#string

P932

22315

http://www.w3.org/2001/XMLSchema#string